Cargando…

Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19”

Detalles Bibliográficos
Autor principal:	Hsieh, Yu‐Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753464/ https://www.ncbi.nlm.nih.gov/pubmed/33362884 http://dx.doi.org/10.1002/joa3.12477

Ejemplares similares

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
por: Henz, Benhur Davi, et al.
Publicado: (2018)

Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2022)

Left Atrial Diameter in the Prediction of Thromboembolic Event and Death in Atrial Fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Unplanned 30-day readmission, comorbidity, and impact on mortality after incident atrial fibrillation hospitalization in Western Australia, 2001–2015
por: Weber, Courtney, et al.
Publicado: (2022)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Editorial Genomics of Atrial Fibrillation and Heart Failure
por: Xiao, Junjie
Publicado: (2015)

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2015)

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Thromboembolic Events Following Atrial Fibrillation Cardioversion and Ablation: What’s the Culprit?
por: De Sensi, Francesco, et al.
Publicado: (2019)

Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Effects of Prevalent and Incident Atrial Fibrillation on Renal Outcome, Cardiovascular Events, and Mortality in Patients with Chronic Kidney Disease
por: Hsu, Hsin-Hui, et al.
Publicado: (2019)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Institutional Variation in 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation
por: Ngo, Linh, et al.
Publicado: (2022)

Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis
por: Liu, Menghui, et al.
Publicado: (2017)

Effects of Prevalent and Incident Chronic Kidney Disease on Cardiovascular Events in Patients with Atrial Fibrillation
por: Lin, Hsuan-Yu, et al.
Publicado: (2019)

Relationship between coarse F waves and thromboembolic events in patients with permanent atrial fibrillation
por: İçen, Yahya Kemal, et al.
Publicado: (2020)

Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
por: ABDULLAH, Ahmad Salihin, et al.
Publicado: (2022)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Decreasing incidence of venous thromboembolic events after radical cystectomy: are we finally improving?
por: Harper, Benjamin T., et al.
Publicado: (2018)

Correction to: Institutional Variation in 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation
Publicado: (2022)

Editorial to “effectiveness of catheter ablation of atrial fibrillation according to heart failure etiology”
por: Bazoukis, George, et al.
Publicado: (2019)

Effect of mean heart rate on 30-day mortality in ischemic stroke with atrial fibrillation: Data from the MIMIC-IV database
por: Yao, Shao-li, et al.
Publicado: (2022)

Atrial Fibrillation
por: Gassanov, Natig, et al.
Publicado: (2013)

Atrial Fibrillation
por: Erol, Çetin
Publicado: (2022)

Editorial to “The differences of atrial thrombus locations and variable response to anticoagulation in non‐valvular atrial fibrillation with ventricular cardiomyopathy”
por: Chung, Wei‐Hsin, et al.
Publicado: (2020)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Myocardial infarction, atrial fibrillation and mortality: timing is everything
por: van den Berg, N.W.E., et al.
Publicado: (2015)

Increased Hb Levels Are Associated with the Incidence of Atrial Fibrillation: But Is It Related to the Occurrence of Stroke?
por: Park, Junbeom
Publicado: (2020)

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial
por: Disertori, Marcello, et al.
Publicado: (2013)

Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

A systematic review protocol for examining 30-day readmission costs for atrial fibrillation patients
por: Woods, Taylor-Jade, et al.
Publicado: (2019)

The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis
por: Hsieh, Hui-ling, et al.
Publicado: (2020)

(How) Can We Reduce Violence Against Women by 50% over the Next 30 Years?
por: Jewkes, Rachel
Publicado: (2014)

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients With Heart Failure Exacerbation and Atrial Fibrillation: A Cross-Sectional Study
por: Gangu, Karthik, et al.
Publicado: (2022)

Age-dependent thrombin generation predicts 30-day mortality and symptomatic thromboembolism after multiple trauma
por: Lesbo, Maj, et al.
Publicado: (2023)

Mortality decrease from cardiovascular disease in Europe: 50 % in 30 years!
por: van der Wall, E. E.
Publicado: (2013)

Characteristics of patients with venous thromboembolism and atrial fibrillation in Venezuela
por: Bennett, Dimitri, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vm3snros1jjnjqb7lr9rk9crfs